SERIES A LAB · CONTROL TO SERIES B · B2B SAAS & AI FOUNDERS · $5M–$10M ARR

From hypergrowth to investor-grade control

You have the team, the ARR, and the board. What you don't have is a control narrative that holds up under real diligence. CAC is drifting. NRR isn't compounding the way it should. The board meetings are getting harder. The Series A Lab is a 12-week sprint to rebuild that clarity — before your Series B investors ask why you waited.

Application only. From $1,497 per startup or 3 installments of $499. No equity taken.

12 weeks
8-10 founders per cohort
$5M–$10M ARR
demo day
image of people working in an office setting (for an ai saas company)
THE OPERATORS IN YOUR corner HAVE BUILT AT

WHO THIS IS FOR

You built the machine. Now you need to control it.

This Lab is for B2B SaaS and AI founders between $5M and $25M ARR who have real growth but are starting to lose the clarity that got them here. The GTM motion that worked at $2M is straining at $10M. CAC is drifting and you don't have a concrete plan to bring it back. The board meetings feel less collaborative and more interrogative. You're managing people who manage people for the first time — and the signal is getting lost in the layers. You know the Series B story needs to be about control and efficiency. Right now, neither word fully describes what you're living. That's not a failure. That's exactly the stage this Lab is built for.

#1 THE BOARD MEETING

You have slides. What you don't have is a control narrative — a clear story about what's working, what isn't, and exactly what you're doing about it. The board is starting to notice the difference. The questions are getting harder and your answers are getting longer.

[background image] image of a writing desk with a laptop (for an insurance agency & company)

#2: THE CAC REVIEW

CAC payback is drifting. You know it. Your CFO knows it. You have a theory about why — but not a concrete, operator-tested plan to bring it back before the next investor update. Every quarter you say you'll fix it. Every quarter something else takes priority.

image of logistics planning session

#3: THE LEADERSHIP MEETING

You're spending all day in meetings you didn't design. You're losing touch with the product and the pipeline. The decisions that used to take you 10 minutes now take three rounds of Slack and a 45-minute call. The org has layers. The signal doesn't make it through them.

image of individuals using real estate tech

#4: THE SERIES B PREP

You know the Series B process is 12–18 months away. You also know your current metrics don't yet tell the story you need them to tell. You're not sure which numbers to fix first — and you definitely don't have the control narrative that holds up when a Series B investor asks the hard questions in diligence.

image of a brainstorming session (for a consulting firm)

#5: THE REAL QUESTION

You don't need another OKR framework or a 60-slide strategy deck. You need operators who've run a company at your exact stage to sit in the room, look at your actual metrics, and tell you which levers to pull first — before the board asks why you didn't.

image of recruitment process for a consulting firm

Note: That's not a failure. That's seed stage. The Lab is built to close exactly that gap — in 12 weeks, on your actual GTM motion, your actual numbers, and your actual company.

Not a fit if:

not for you

You're pre-Series A or under $5M ARR.

If you're still building the initial GTM motion and haven't yet hit the complexity wall, the Seed Lab is the right starting point. The Series A Lab is for founders who have growth but are losing control of the efficiency behind it.

not for you

You want a framework deck, not a working session.

If you're looking for a methodology to implement on your own later, this isn't the right format. Every session works on your actual Control Scorecard, your actual GTM map, and your actual board narrative.

not for you

You're not willing to show your real numbers.

The Series A Lab runs on honesty — drifting CAC, stalling NRR, uncomfortable burn multiples. If you need your metrics to look clean before you can get useful feedback, wait until you're ready.

THE SEries A TRAP

Growth got you here. The same approach won't get you to Series B.

Every Series A founder hits the same wall. ARR is real. The team is growing. But three things are silently working against you — and they compound the longer you wait.

image of game development process (for a mobile gaming) - collaborative team meeting
PROBLEM #1

Your growth is real. Your efficiency story isn't — and the board knows it.

CAC payback is drifting past 18–24 months. NRR is stuck near 100–105% when it should be compounding. Burn multiple is creeping up. Each of these has a specific cause — wrong ICP mix, a motion that was never redesigned for this stage, pricing that evolved deal-by-deal, or an org structure that adds cost faster than it adds output. You have a theory. You don't have a plan. And Series B investors will ask for the plan before they ask about the growth rate.

[interface] image of customizable settings dashboard (for a ai fintech company)
PROBLEM #2

You have multiple motions, markets, and ICPs — and no clear view of which ones actually deserve fuel.

At $2M ARR you could afford to test everything. At $10M ARR you can't. But you still have three ICPs, two geos, and four internal opinions on what's working. Everyone has a story that supports their segment. The data doesn't tell a simple story. The result: you're funding everything moderately well instead of one thing exceptionally well — and Series B investors can see it in your CAC and NRR by segment.

[background image] image of a desk with tech gadgets (for a ai developer tools)
PROBLEM #3

You don't have the control narrative your board needs — or the one Series B investors will demand.

CAC payback by segment. NRR by cohort. Burn multiple by scenario. Rule of 40 trend. These aren't just metrics — they're the language Series B investors use to decide whether you have a machine or a moment. Right now they live in three tools, a CFO model, and your memory. Every board meeting is assembled the night before. And the narrative you present explains the past without convincing anyone about the future.

Note: This Lab exists to rebuild that clarity in 12 weeks — on your actual metrics, your actual GTM motion, and the control narrative your next raise depends on.
THE 12-WEEK ARC

Every week, one lever.
Twelve weeks, a company your board can underwrite.

The Lab isn't a curriculum. It's a compressed control sprint — parallel tracks running from Week 1. You're not spending four weeks on frameworks before you touch your metrics. You're diagnosing, deciding, rebuilding, and stress-testing simultaneously — the way a Series A company that's serious about Series B actually has to operate.

Phase 1 — Weeks 1–2: Control Baseline & Metric Diagnosis

What this phase is for: Before you can fix anything, you need an honest read of where you actually are. Not the board-deck version — the real version. Week 1 produces your Control Scorecard baseline. Week 2 tells you which metrics are genuinely red and which are yellow dressed up as green.

Week 1 — Control Scorecard Baseline
Output you'll produce: Your first live Control Scorecard — CAC payback by key segment, NRR by cohort, burn multiple, sales efficiency, Rule of 40, and runway. Built from your actual data, not a template. You present it to the cohort. The room tells you what's drifting, what's structurally broken, and what's actually fine but looks bad because it's not presented clearly.

Week 2 — Red/Yellow/Green Diagnosis & Priority Stack
Output you'll produce: A prioritised diagnosis — which metrics are genuinely red (require immediate intervention), which are yellow (need a plan but not a crisis), and which are green (leave alone and stop worrying about). You present your honest read. A CFO/metrics mentor joins to pressure-test the diagnosis and make sure you're not misreading a structural problem as a temporary blip — or vice versa.

Phase 2 — Weeks 3–4: GTM Map & Leak Diagnosis

What this phase is for: CAC drifts for specific reasons. NRR stalls for specific reasons. This phase builds the GTM map that shows you exactly where pipeline is leaking, where deals are dying, and where expansion is failing — and ties each leak back to a specific metric.

Week 3 — GTM Map v1: ICP, Channel & Conversion View
Output you'll produce: A live GTM map — every ICP, every channel, and conversion rates at each stage by segment. Not a slide about your motion — a live view of where revenue is actually coming from, what it costs to acquire, and which segments are efficient vs. which are quietly dragging your CAC. You present it to the cohort. The room tells you which segments to cut before you have the conversation.

Week 4 — Leak Diagnosis & Segment Truth
Output you'll produce: A GTM leak map — where pipeline is dying, where deals are stalling, where expansion is failing, and which of these is a motion problem vs. an ICP problem vs. a product problem. You present: "Here's where I thought the problem was. Here's where the data says it actually is." A GTM operator joins to show you the patterns they've seen at your exact stage and what they did about them.

Phase — Weeks 5–6: Pricing, Packaging & NRR Lever

What this phase is for: NRR is the metric that separates Series A companies that compound from ones that plateau. This phase unpacks how pricing and packaging are actually working in the field — and designs 2–3 targeted experiments to move NRR without blowing up existing deals.

Week 5 — Pricing & Packaging Audit
Output you'll produce: An honest pricing and packaging audit — how deals are actually being sold vs. how they were designed, where discounting is happening and why, which packages are expanding vs. which are churning, and what your NRR would look like if packaging worked as intended. You present the gap between pricing design and pricing reality. A pricing/revenue operator joins to tell you what they'd change first.

Week 6 — NRR Experiment Design
Output you'll produce: 2–3 NRR experiment designs — specific, targeted changes to packaging, expansion triggers, or CS motion with clear hypotheses, success metrics, and guardrails that prevent them from breaking existing revenue. You present the experiment brief to the cohort. The room stress-tests each one before you run it on live customers.

Phase 4 — Weeks 7–8: Org Ownership, Operating Cadence & CEO Stance

What this phase is for: At Series A, the efficiency problem is often an ownership problem. Everyone owns growth. Nobody owns the specific metric that's drifting. This phase clarifies GTM and RevOps ownership across teams — and builds the weekly CEO operating cadence that keeps the control metrics visible and actioned.

Week 7 — GTM & RevOps Ownership Map
Output you'll produce: A GTM/RevOps RACI — who owns CAC payback, who owns NRR, who owns pipeline health, who owns the board narrative. Not a job description exercise. A decision about where accountability actually lives and what that means for your weekly operating rhythm. You present the ownership map. A GTM/RevOps operator joins to show you the exact ownership gaps that cause control to slip at your stage.

Week 8 — Weekly CEO Cadence & Control Rhythm
Output you'll produce: A written weekly CEO operating cadence — Monday metrics review (30 min), Wednesday GTM/product sync (45 min), Friday board-readiness check (15 min), monthly investor update process. You present your first full week of running the cadence. The cohort tells you what's still running through you that shouldn't be — and what's still invisible that needs a home in the rhythm

Phase 5 — Week 9: Choose Your Levers & Build the Control Plan

What this phase is for: You've diagnosed the metrics, mapped the GTM leaks, audited pricing, and clarified ownership. Now you choose 2–3 high-leverage plays that move multiple KPIs at once — and turn them into a 6–12 month Control Plan with owners, milestones, and metrics.

Week 9 — Control Plan v1
Output you'll produce: A written Control Plan — 2–3 lever plays (e.g., tighten ICP/channel focus to compress CAC, redesign CS expansion motion to lift NRR, restructure packaging to improve payback period), each with a specific hypothesis, a metric target, an owner, and a 90-day milestone. You present the plan to the cohort. The room tells you what's ambitious-but-realistic and what's wishful thinking dressed up as a plan.

Phase 6 — Week 10: Board-Grade Narrative & Series B Story

What this phase is for: Turn the Control Plan into the narrative your board needs to hear and your Series B investors will demand. Not the growth story — the control story. Where control slipped, what you're doing about it, how you'll know it's working, and when you'll change course.

Week 10 — Board Narrative & Series B Control Story
Output you'll produce: A board-ready control narrative — here's where efficiency slipped and why, here's the Control Plan and the 2–3 levers we're pulling, here's how we're measuring progress, here's what the company looks like in 12 months if the plan works. You present a 7–10 minute board-style narrative. A Series B investor joins to give you the feedback they'd give in a real first meeting — the questions they'd ask, the numbers they'd probe, and the narrative gaps they'd flag before you're actually in the process.

Phase 7 — Weeks 11–12: Execute, Refine & Demo Day

What this phase is for: Run the early weeks of the Control Plan, bring real data and real resistance back into the room, and refine the narrative based on what you've learned. Week 12 is Demo Day — the final sprint, the forcing function, the presentation that proves the control layer is real.

Week 11 — First Control Plan Results & Narrative Refinement
Output you'll produce: An updated Control Scorecard showing first movement on your lever plays, a refined Control Plan based on what the first 2–3 weeks of execution revealed, and a tightened Series B narrative that incorporates what's changed. You present: "Here's what the plan said. Here's what the data said. Here's what we changed and why." The cohort pressure-tests your before/after.

Week 12 — Demo Day
Output you'll produce: Your final Control Scorecard, Control Plan, and Series B narrative — presented live in front of invited Series B VCs, growth-stage investors, and operators who've taken companies through the exact raise you're preparing for. You present what you built. They respond as investors. Expect real questions on your CAC trend, your NRR lever plan, and the ownership structure behind the metrics.

Week 0: founder-led revenue, no motion, no dashboard, every fire on your desk.
Week 12: a documented GTM motion your first hire can run, a live traction dashboard, product signal tracked, an ownership map that removes you from the day-to-day, and a Series A story built on proof — not projection. That's the arc. Every week is one step on it.
WHAT YOU LEAVE WITH

Six deliverables.
All yours. All running.

At the end of 12 weeks, you don't leave with a certificate. You leave with a working control system — and the outputs that prove it to your board, your exec team, and your Series B investors.

OutPUT #1

A live Control Scorecard — your single source of truth.

CAC payback by segment, NRR by cohort, burn multiple, sales efficiency, Rule of 40, and runway — in one view, reviewed every week. Built on your actual data in Week 1, running every Monday by Week 12. No more assembling the board narrative the night before.

OutPUT #2

A GTM map that shows exactly where to double down and where to cut.

A live view of every ICP, every channel, and conversion rates at each stage by segment — with a leak map that shows where pipeline is dying, where deals are stalling, and where expansion is failing. The document that ends the internal debate about which segments actually deserve fuel.

OutPUT #3

A pricing and packaging audit + 2–3 live NRR experiments.

An honest read of how deals are actually being sold vs. how they were designed — and 2–3 targeted experiment designs with clear hypotheses, success metrics, and guardrails. Built in Weeks 5–6. Running in the market before Demo Day.

OutPUT #4

A GTM/RevOps ownership map and weekly CEO cadence.

A clear RACI for who owns CAC, NRR, pipeline health, and the board narrative — plus a written weekly CEO operating rhythm that keeps the control metrics visible and actioned without every decision running through you. Built in Week 7. Running by Week 8.

OutPUT #5

A written Control Plan — 2–3 levers, owners, and 90-day milestones.

Not a list of initiatives. A focused plan: 2–3 high-leverage plays that move multiple KPIs at once, each with a specific hypothesis, a metric target, an owner, and a milestone your board can track. Presenting in Week 9. Showing early movement by Week 11.

OutPUT#6

A Series B control narrative built on what you proved — not what you're projecting.

A board-ready control story — where efficiency slipped, what you did about it, how you're measuring progress, and what the company looks like in 12 months. The version that holds up when a Series B investor asks the hardest questions, because it's grounded in 12 weeks of real operating work.

Plus: The FSC Series A Seal
Awarded at Demo Day to founders who complete all 12 sprints and present their final output. Evidence that you built the control layer — a live Control Scorecard, a GTM map, a Control Plan with owners, and a Series B narrative grounded in real metrics. Not a signal that you attended a program.

SERIES a  stage REALITY

What Week 0 looks like. What Week 12 looks like.

Most Series A Lab founders arrive at the same starting line. Here's what it looks like — and what's waiting on the other side.

WEEK 0 · THE METRICS

"CAC is drifting and I have a theory — but not a plan I can defend in front of the board."

You know the numbers are moving in the wrong direction. You've looked at the data. You have a hypothesis. But you don't have a prioritised diagnosis that tells you which metric to fix first, what's causing it, and what a realistic improvement plan looks like. The board meeting is in three weeks.

WEEK 0 · THE GTM MAP

"We have multiple ICPs and motions — I'm not sure which ones are actually efficient."

At $2M you could fund everything. At $10M you can't. But you're still running three segments with four internal opinions on what's working. The CAC by segment data exists somewhere. Nobody's looked at it honestly in six months.

WEEK 0 · THE BOARD NARRATIVE

"The board deck takes me two days to build and I'm still not confident in the story it tells."

You have slides. You have data. What you don't have is a control narrative — a clear, defensible story about what's working, what isn't, what you're doing about it, and how you'll know it's working. The board is starting to notice the gap between the growth rate and the efficiency story.

WEEK 0 · THE SERIES B STORY

"I know the Series B process is coming. I also know my metrics don't yet tell the story I need them to tell."

You have 12–18 months. You're not sure which numbers to fix first, which narrative to build, or how to get from where you are to a control story that Series B investors can underwrite. Every week you mean to start. Every week something more urgent wins.

HOW IT WORKS

The same rhythm, every week.
No ambiguity about what to do next.

The Lab runs on a simple weekly loop. You know exactly what's expected, what you'll produce, and what happens in the session. No passive learning. No optional homework. Every session works on your actual Control Scorecard, your actual GTM map, and your actual board narrative — at the pace of a company that has a Series B timeline and can't afford to move slowly.

[background image] image of collaborative workspace (for a ai legal tech company)

STEP 1

SPRINT BRIEF
(delivered Thursday)

Every week starts with a focused sprint pack in your workspace: the theme of the week, the required output, the template to start from, and the operator joining that session. You don't start from a blank page — you start from a proven format built for founders at your exact stage.

image of individuals using real estate tech

STEP 2

YOU DO THE WORK (Thursday–Wednesday, 3–5 hours)

You produce the output. Not a reflection on the topic — the actual deliverable. A live Control Scorecard. A GTM leak map. A pricing audit. A Control Plan. A board narrative. Something you can put in front of the cohort and defend against operators who've fixed the same metrics at your exact stage.

[team]

STEP 3

COHORT SESSION
(Thursday, 60 mins)

60 minutes live on Zoom. A short framing from Yannick, then hot seats — founders present their weekly output, get direct feedback from Yannick and the week's operator guest, and leave with a specific next action. You come in with your work. You leave with a decision.

image of accountants in action

STEP 4

OFFICE HOURS
(3xweek, 60 mins each)

The week's specialist operator — CFO/metrics mentor, GTM/RevOps operator, pricing advisor, or Series B investor — holds focused office hours for the cohort. Live reviews of your Control Scorecard, your GTM map, your NRR experiment design, your Control Plan, your board narrative. The right expert in the room on the week it matters most.

Sprint brief → Do the work → Present it → Operator feedback → Refine. Repeat for 12 weeks. That's the whole system. It's simple because it has to be — you're also running a $10M+ company.

The workspace:

Between sessions, you have access to your private cohort workspace: all sprint packs, templates, session replays, and the cohort channel. And continuous access to the CEO Operating Room — the always-on room for anything not fully resolved in the cohort session.

What the Lab requires:

3–5 hours per week. Real numbers — even if they're uncomfortable. Willingness to show your work to the group so you get real feedback. No selling services to other founders in the room — this is about your Control Scorecard, your GTM map, and your Series B story.

THE MENTOR TEAM

The operators across the table.

The Lab is led by Yannick and supported by rotating specialist operators matched to each week's sprint. Not advisors who remember what Series A was like. Founders, operators, and investors who've built control systems under real board pressure, fixed drifting CAC on live companies, and walked into Series B processes with a narrative that held up — back in the room because this is the stage where control either gets built or quietly costs you the raise.

YOUR LAB LEAD

Yannick Kpodar

15+ years scaling B2B SaaS across the US and Europe.

Helped teams raise $396M, reach unicorn status, and build GTM and control systems that hold up in any board room. Founder of Full Stack CEO.


I've sat on both sides of the Series A-to-B table. As a VP and CMO helping B2B SaaS companies navigate the exact inflection point you're at — fast growth, drifting efficiency, board pressure building. And as a GP at Aventra Capital evaluating whether a Series A company has the control narrative to deserve a Series B. I know exactly what the metrics need to say, what the board needs to hear, and what most Series A founders are missing when the conversation gets hard. I lead every cohort session, run every hot seat, and own the sprint arc from Week 1 to Demo Day.

GP @ Aventra Capital
ex-LinkedIn · PayFit · Amenitiz
15+ years B2B SaaS
image of people working in an office setting (for an ai saas company)
THE OPERATOR BENCH

Specialists in the room when it matters most.

$2.2B+ raised collectively. 23+ exits. 12 unicorns built or scaled. 4 IPOs. 25+ operators showing up every week. These aren't people who once built a company and now talk about it. They're in the room because early-stage founders ask the questions that actually matter — and they have the receipts to answer them.

[headshot] image of customer
Indy Sen
GTM
PRODUCT MARKETING
ex-Google, Salesforce, Canva, MuleSoft · 3 IPOs

Indy has built GTM at a $2B run rate at Google and taken three companies public. He's operated at exactly the scale and complexity a Series A founder is trying to get under control.

His lens at this stage is platform and ecosystem: when your single product motion starts straining, what does the multi-product or platform GTM look like, and how do you redesign the motion without breaking the revenue you already have? He helps founders make the GTM architecture decision before they hire an executive to execute the wrong one.

📍Location: San Francisco, CA
[headshot] image of customer (for a university)
David Ehrlich
CEO OPERATIONS
CAPITAL
ex-CEO Aktana (12 years), McKinsey, Stanford

David ran Aktana for 12 years at 200% CAGR — which means he's lived every board meeting where the CAC question came up and the answer wasn't clean. He's been on the CEO side of that table, and as a Board Director across 10+ companies, he's been on the investor side too.

At Series A, he's the operator in the room who looks at your control narrative, your efficiency metrics, and your board slide and tells you exactly what's missing before a Series B investor does.

📍Location: Berkeley, CA
[headshot]
Denis Descause
AI
GTM
M&A
Founder & GTM · ex-SAP, BCG · €200M SaaS revenue

Denis spent 11 years at SAP shaping the M&A strategy behind SuccessFactors, Ariba, and BusinessObjects — which means he's evaluated hundreds of Series A companies from the acquirer's side. He then founded and sold Flashbrand himself, profitably, without external funding.

At Series A, he brings both lenses: what does your control narrative look like to a strategic buyer or late-stage investor, and what needs to be true about your CAC, NRR, and GTM efficiency before that conversation goes well?

📍Location: New York, NY
[headshot] image of customer (for a home inspector)
Alon Maltzov
product
ai
2x Founder · 1 exit · $15M→$25M ARR

Post-acquisition at Teikametrics, Alon ran a platform at $15M–$25M ARR where churn was the defining metric. He cut it 55% in 18 months — not by rebuilding the product, but by redesigning the retention motion.

At Series A, NRR is the number that separates companies that compound from companies that sprint. Alon comes in specifically when NRR is stuck near 100–105% and the founding team doesn't yet have a concrete lever plan to move it — before that number becomes the hardest slide in the Series B deck.

📍Location: San Francisco, CA
[headshot] image of customer for an insurance agency & company
Sachin Shah
PRODUCT
AI
TECH
ex-Bain (NPSx), Accenture · Fractional CTO

At NPSx, Sachin managed a multi-million dollar engineering budget, built a team from 0 to 45, and delivered ISO certification across four products in 12 months — under board-level scrutiny from Bain as the main investor. He knows what it looks like when engineering spend becomes a board question and R&D can't defend its output.

At Series A, he helps founders build the technical operating rhythm and AI architecture that makes engineering spend visible, defensible, and aligned to the metrics that matter to a Series B investor.

📍Location: London, UK
[headshot] image of customer (for a dental office)
Betty Mok
GTM
DEMAND GEN
SVP Marketing · Consensus ·  
ex-LinkedIn, Pendo, Intuit, AmEx

Betty managed a $20M+ marketing budget at LinkedIn's Talent Solutions and ran all of Pendo's performance marketing — demand gen, PLG, customer marketing, and digital — simultaneously. She's built the GTM engine at the scale Series A founders are trying to reach.

At this stage, her focus shifts from motion design to efficiency: which channels have real CAC leverage, which don't, and how do you build a demand gen system that compounds NRR instead of just adding logos that churn at renewal.

📍Location: San Francisco, CA
[headshot] image of customer (for a gym)
Vivek Bedi
PRODUCT
AI
aCQUISITIONS
ex-Goldman Sachs, Northwestern Mutual · $2B+ acquisitions

Vivek doubled SimplifyVMS ARR from $25M to $50M and then led it to a ~$500M PE acquisition. He's also been on the diligence side — at Goldman Sachs, he led product and technology due diligence contributing to $1B+ in funding decisions. He knows exactly what a Series B investor sees when they open a data room.

At Series A, his lens is efficiency and acquisition readiness: where is PLG creating compounding NRR, where is the product creating churn, and what needs to change before diligence surfaces it for you.

📍Location: New York, NY
[headshot] image of customer (for a fine dining restaurant)
Todd Etchieson
PRODUCT
AI
Fractional CPO · Apex Solutions
ex-Conversica, New Relic, Nike, Nortel

Todd's entire career has been spent in the $7M–$25M ARR range — the exact stage where product organizations quietly break. At New Relic, he reset an overcommitted roadmap, reduced customer-bound commitments from 18 to 8 months, and drove a 10% ARR uplift. At Conversica, he unified fragmented roadmaps and cut time-to-market 25%.

He comes into the Series A track specifically for founders where R&D looks like a black box to the board — and helps you build the product operating rhythm that makes every spend defensible.

📍Location: Portland, OR

Note: Each cohort also has one exited founder as anchor mentor for the full 12 weeks — someone who's been through the seed-to-Series-A moment and comes back every week because they know how fast things shift when the machine starts to work.
WHY THEY'RE HERE

Not advisors who lend their name.

They show up in the sessions, review your work, and give feedback they'd stand behind in any board room.

[background image] image of a busy hospital corridor

“I've worked with companied from 98,000 employees and $30B in revenue to 5 employees and $1M in revenue. I've acquired and been acquired. I've been through an IPO and also through a meltdown. I've seen a lot and I'm here to help CEOs make better decision from day one.”

Todd Etchieson
Fractional Chief Product Officer, Apex Solutions
[background image] image of collaborative workspace (for a blockchain and cryptocurrency)

“I've been a CEO and I know it's a pretty lonely job. There's a million things to navigate. I've sat on many boards and my objective is to be a truth teller to CEOs. To provide them with insights to course correct and make the best decisions for the best path forward.”

Juan Carlos Soto
Board Chairman, Advisor, former CEO, Venture Partner, Fractional CxO
image of content management strategy session

“I've done pretty much all of the roles inside in software service company from strategy to pre-sales, sales support, consulting, HR, and CEO. I have a 360 view of a company today across several industries. My objective is to help founders go from origins to Series B.”

Denis Descause
C-Level Executive & AI Entrepreneur | 0 to $200M+ Revenue Growth
image of expert panel discussing blockchain

“I've led product and digital at 4 different hypergrowth stages. Smallest scaled it from $5M to $25M. Largest from $250M to $340M. All four led to an acquisition. This next chapter in my life is about value creation, mentoring, advising. I sit on six board and I'm here to help.”

Vivek Bedi
Head of AI & Product Innovation @ Litera
WHY THIS WORKS

Four things that don't exist in consultants, courses, or accelerators.

The Lab works because of how it's structured — not just what it covers. At Series A, the gap between knowing which metrics are drifting and actually having a plan to move them is where most control narratives collapse. The Lab closes that gap by running parallel tracks from Week 1 — diagnosis, GTM map, pricing audit, ownership, and board narrative all running simultaneously, the way a Series A company with a real Series B timeline has to operate.

HOW WE WORK

1 — Hot seats, not lectures


Every cohort session has a teaching frame — 15–20 minutes on the week's concept. The rest of the session is hot seats: you present your sprint output, the room gives direct feedback, Yannick and the week's operator challenge your Control Scorecard numbers, your GTM leak diagnosis, your NRR experiment design, your Control Plan logic. You're not watching someone else learn. You're in the chair.

image of a community center project
WHO'S IN THE ROOM

2 — Operators, not instructors

The people who give feedback in the Lab aren't coaches with a methodology. They're operators, exited founders, and investors who've done the specific thing you're trying to do — built a Control Scorecard under real board pressure, fixed drifting CAC on a live company, designed NRR experiments that didn't break existing revenue, put together a Series B control narrative that held up in diligence. They give you the feedback they'd give a founder they were backing.

[team]
YOUR COHORT

3 — A cohort that compounds

8–12 founders at your exact stage, working on the same problem at the same moment. By Week 2, they know your metric diagnosis. By Week 5, they're stress-testing your NRR experiment designs. By Week 9, they're pressure-testing your Control Plan before it goes to your board. The accountability isn't external — it comes from a room of people who've watched you build the control layer from the data up.

image of finance data analysis
BETWEEN SESSIONS

4 — CEO Operating Room

Every Lab participant has continuous access to the CEO Operating Room — the always-on community where you can get a fast read on a board question, unblock a metrics decision, or stay in motion between weekly sprints. The control work doesn't pause because it's Thursday.

[team]

How FSC is different

1v1 comparisons vs accelerators, online courses, going at it alone, or waiting for traction before getting started.

WEEK 12

You present to the room.

Every Series A Lab ends with Demo Day. Not a ceremony. A forcing function.

image of a marketing strategy meeting
WHAT YOU PRESENT

Your Series B story — built on 12 weeks of real control work.

Your live Control Scorecard with first movement on your key metrics, your GTM map, your Control Plan with owners and milestones, and your board-ready control narrative — here's where efficiency slipped, here's what we did about it, here's how we're measuring progress, here's what the company looks like in 12 months. You've spent 12 weeks building it on your actual data. The cohort has pressure-tested every piece. Demo Day is where you deliver it to investors seeing it for the first time. Expect real questions on your CAC trend, your NRR lever plan, and the ownership structure behind the metrics.

[background image] image of futuristic technology (for a data analytics and business intelligence)
WHO ATTENDS

Your cohort, your mentors, and stage-matched investors.

Your cohort and the full mentor team. Plus external guests selected for stage relevance: Series B VCs, growth-stage investors, and operators who've taken companies through the exact raise you're preparing for — there to give real feedback, not to applaud.

image of meeting with financial advisors [scene 1]
WHAT IT ISN'T

Not a competition. Not a showcase.

Demo Day at FSC has no ranking, no prize, no winner. It's the Demo Day at FSC has no ranking, no prize, no winner. It's the final sprint — a forcing function to make sure your Control Scorecard shows movement, your Control Plan has owners, and your narrative holds up under pressure from investors who've seen what good looks like. The feedback is the last session. The relationships that come from it are earned.final sprint — a forcing function to make sure your motion is documented, your numbers are clean, your product signal is tracked, and your narrative holds up under pressure. The feedback is the last session. The relationships that come from it are earned.

THE FSC SEED SEAL

Built the control layer.

Founders who complete all 12 sprints, present at Demo Day, and deliver their final output earn the FSC Series A Seal — the Full Stack CEO certification for Series A-stage control work.

GP @ Aventra Capital
ex-LinkedIn · PayFit · Amenitiz
15+ years B2B SaaS
image of people working in an office setting (for an ai saas company)
image of game development process (for a mobile gaming) - collaborative team meeting
WHAT IT SIGNALS

Evidence of the control layer, not attendance.

You didn't watch a course on metrics strategy. You spent 12 weeks building a live Control Scorecard on your actual data, diagnosing your GTM leaks, auditing your pricing, designing NRR experiments, clarifying ownership across your org, building the board narrative, and producing a Series B story grounded in real operating work — with operators reviewing every output and a cohort holding you to account every week. The Seal is evidence of that system.

[interface] image of customizable settings dashboard (for a ai fintech company)
HOW TO USE IT

Put it where investors can see it.

Add it to your LinkedIn profile under Certifications. Reference it in Series B conversations as evidence of rigorous control work. It signals to FSC-network investors and operators that you built the control layer — not just the ARR.

[background image] image of a desk with tech gadgets (for a ai developer tools)
REQUIREMENTS

You have to earn it.

— Attended 8 of 12 cohort sessions
— Submitted and presented sprint outputs for Weeks 1, 3, 9, and 10
— Presented at Demo Day
— Delivered the final Control Scorecard and Series B narrative output

"This is not a certificate for showing up. It's a credential for doing the work — with evidence."

THE STAGE LABS · PRICING

One fixed fee.
No equity. No strings.

All Lab pricing is per startup. Co-founders are both welcome in sessions.

Each sprint includes:

  • 12-week live sprint with a clear start date, end date, and stage-specific outcomes

  • Weekly cohort sessions where you build your scoreboard, GTM plan, and experiments in real time

  • Direct feedback from exited founders, operators, and VCs on your metrics, decks, and GTM decisions

  • Structured sprint templates so you know exactly what to produce each week between sessions

  • Access to the CEO Operating Room throughout the Lab (and discounted after)

  • Demo Day with invited investors and operators in the room + FSC Lab Seal upon completion

Note: Applications are reviewed within 48 hours. We only accept founders we believe we can genuinely help. If it's not the right fit or the right timing, we'll tell you — and point you somewhere better if we can.

CEO OPERATING ROOM

NOT READY TO APPLY YET?

Start in the CEO Operating Room first. The always-on base for seed founders — weekly sessions, operator AMAs, GTM templates, and peers at your stage. $49/month. No application.

image of consulting setup
YOUR BASE · ALWAYS ON

The CEO
Operating Room

For B2B SaaS and AI founders at any stage who want the room, the operators, and the weekly sessions — without a sprint commitment.

$49 / month
or $470 / year (2 months free)

What's included:

- Weekly live sessions at your stage — Pre-Seed, Seed, or Series A

- Private Slack — real peers, no pitch culture, no noise

- Operator AMAs every week — exited founders, active VCs, senior operators

- Full template library — GTM playbooks, scorecards, pitch frameworks, dashboards

- Every session archived and searchable

- Access to all FSC free weekly events

Frequently asked questions

Answers to the real questions.

If something isn't covered here, start in the CEO Operating Room — the room will answer it faster than any FAQ.

READY TO BUILD THE CONTROL LAYER?

Growth got you here. Control gets you to Series B.

The Series A Lab runs in small cohorts. Every seat is filled by application. If you're serious about rebuilding control of your metrics, your GTM motion, and your board narrative in 12 weeks — with operators who've done it and a cohort that holds you to account — apply now.

CEO Operating Room: The always-on base for Series A founders. Weekly sessions, operator AMAs, templates, and peers at your stage. $49/month. No application. Cancel anytime.

image of an industry conference (for an ai marketing tech company)